The Jacobs Institute, and its Board of Governors, approved the following statement regarding the approval of Plan B:
Whereas Plan B has been approved by the Food and Drug Administration for prescription use since 1999;
Whereas Plan B is a safe and effective way to prevent pregnancy when backup contraceptive methods fail or rape or other sexual violence occurs;
Whereas medical evidence has shown that Plan B is safe, effective, and appropriate for women of all ages;
Whereas Plan B holds enormous potential to prevent up to half of the 3 million unintended pregnancies annually;
Whereas Plan B’s effectiveness is completely contingent on a woman’s timely access to the drug;
Whereas respected professional medical organizations have estimated that greater access to emergency contraception could significantly reduce the US abortion rate;
Whereas no studies have shown that teenage girls’ access to emergency contraception will lead to greater rates of promiscuity and/or abuse;
Whereas a joint hearing of the FDA Nonprescription Drugs and Reproductive Health Drugs Advisory Committees voted 23 to 4 to recommend the FDA make Plan B available over the counter: Now, therefore, be it
Resolved, by the Jacobs Institute of Women’s Health, That the Board of Governors --
(1) Request the FDA to reverse its decision to deny access of Plan B over the counter; and
(2) Encourage the FDA to make future decisions based on scientific evidence.
Women: Stay Healthy at Any Age
What can you do to stay healthy and prevent disease? You can get certain screening tests, take preventative medicine if you need it, and practice healthy behaviors.
Top experts from the U.S. Preventive Services Task Force suggest that when you go for your next checkup, talk to your doctor or nurse about how you can stay healthy no matter what your age.
Lack of Studies on Women Limits Usefulness of Research on Coronary Heart Disease
Although coronary heart disease (CHD) is the cause of more than 250,000 deaths in women each year, much of the research in the last 20 years on the diagnosis and treatment of CHD has either excluded women entirely or included only limited numbers of women and minorities. As a result, many of the tests and therapies that are used to treat women for CHD are based on studies conducted predominantly in men.